Theseus Investor Seeks Appraisal After Concentra Merger

By Leslie A. Pappas · April 2, 2024, 8:28 PM EDT

A fund invested in clinical-stage biopharmaceutical company Theseus Pharmaceuticals Inc. has petitioned Delaware's Court of Chancery for an appraisal of the investor's 250,000 shares following Theseus' $4.05 per-share consolidation in February with...

To view the full article, register now.